8 studies found for:    15496622 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: preoperative short-course radiotherapy with local boost;   Radiation: preoperative short-course radiotherapy without local boost;   Procedure: TME surgery
2 Recruiting Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer
Conditions: Rectal Neoplasms;   Rectal Cancer Stage II;   Rectal Cancer Stage III
Interventions: Drug: Induction Chemotherapy arm A;   Radiation: Radiation arm A;   Radiation: Radiation arm B;   Drug: Chemotherapy arm B;   Procedure: Surgery
3 Completed
Has Results
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
Condition: Rectal Neoplasms
Interventions: Drug: capecitabine;   Drug: Capecitabine
4 Completed Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy
Condition: Rectal Cancer
Intervention: Drug: preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine
5 Completed Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer
Condition: Resectable Rectal Cancer Clinical Stage II and III
Intervention: Drug: Capecitabine
6 Completed Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy
Condition: Rectal Adenocarcinoma
7 Unknown  Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study
Condition: Locally Advanced Rectal Cancer
Intervention: Drug: bevacizumab, capecitabine
8 Active, not recruiting A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab
Condition: Rectal Cancer
Intervention: Drug: Capecitabine, Cetuximab, Oxaliplatin

Indicates status has not been verified in more than two years